Glucagon Emergency Kit Recalled (Class II) Over Stability Test Failure
Lupin Pharmaceuticals recalled Glucagon Emergency Kit vials as a Class II action after an out-of-specification stability test result, effective June 23, 2026.
Read Full ArticleAll News
Liraglutide Injection Recalled (Class II) Over Particulate Matter
Lupin Pharmaceuticals initiated a Class II recall of Liraglutide Injection on April 24, 2026, citing a white thread-like particulate found in cartridges.
Desmopressin Nasal Spray Recalled (Class II) Over Bottle Cap Defect
Apotex Corp. initiated a Class II recall of Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL on April 8, 2026, citing defective bottle cap liners.
Cetrorelix Acetate Injection Kit Recalled (Class II) Over Needle Defect
Meitheal Pharmaceuticals initiated a Class II recall of Cetrorelix Acetate for Injection Kits on Feb 9, 2026, citing missing or duplicated needles in the kits.
Ganirelix Acetate Injection Recalled: Class II, Impurity Issue
Lupin Pharmaceuticals initiated a Class II recall of Ganirelix Acetate Injection on Nov 13, 2025 due to an out of specification impurity result.
Vasopressin Injection Recalled by American Regent (Class II)
American Regent recalled Vasopressin Injection, USP in a Class II action initiated May 13, 2024, citing subpotency and impurity test results.
HUMALOG (Insulin Lispro) Recalled in Class II FDA Action
Eli Lilly & Company initiated a Class II recall of HUMALOG U-100 insulin lispro injection on March 12, 2024, citing CGMP deviations. Status: Completed.
Terlivaz (Terlipressin) Recalled in Class II Action Over Temperature Excursion
Mallinckrodt initiated a Class II recall of Terlivaz (terlipressin) on Feb 6, 2024, citing a temperature excursion from a shipping delay to the distributor.
ELIGARD (Leuprolide) Recall Classified Class III, Status Terminated
Tolmar, Inc. recalled ELIGARD (leuprolide acetate) on 20230912 as a Class III event over superpotent drug levels. Status is terminated.
Calcitonin Salmon Nasal Spray Recalled (Class II) Over Glass Splinter
Apotex Corp. recalled Calcitonin Salmon Nasal Spray in a Class II action after a glass splinter in the pump ball seat made the pump inoperable.
Fyremadel (ganirelix acetate) Recalled in Class II Action
Sun Pharmaceutical Industries Ltd. initiated a Class II recall of Fyremadel (ganirelix acetate) on April 19, 2023 due to particulate matter.
Desmopressin Acetate Tablets Recalled (Class II) Over Subpotency
A Class II recall of Desmopressin Acetate Tablets 0.2mg was initiated on Nov 23, 2022 by Heritage Pharmaceuticals due to subpotent drug levels.
Kinevac (Sincalide) Recall Classified Class II for Temperature Abuse
A Class II recall of Kinevac (Sincalide for Injection) was initiated April 13, 2022, citing cGMP temperature abuse deviations. The recall status is terminated.
Trulicity (Dulaglutide) Class II Recall Over Temperature Abuse
Cardinal Health Inc. initiated a Class II recall of Trulicity (dulaglutide) on April 5, 2022, citing temperature abuse during storage. Status: Completed.
Trulicity Recalled (Class II) Over Autoinjector Labeling Error
Eli Lilly recalled Trulicity (dulaglutide) pens in a Class II action due to a label error on declared strength, initiated August 19, 2021.
Saxenda (Liraglutide) Class II Recall Over Temperature Abuse
Novo Nordisk recalled Saxenda (liraglutide) samples in a Class II action initiated March 22, 2021, citing temperature abuse during storage.
Victoza Recall Classified Class II Over Temperature Storage Issue
A Class II recall of Victoza (liraglutide) was initiated on March 22, 2021, by Novo Nordisk Inc over temperature abuse concerns during storage.
Linzess (linaclotide) Class II Recall Over Temperature Excursion
Cardinal Health Inc. initiated a Class II recall of Linzess (linaclotide) capsules on March 15, 2021 due to storage temperature excursion. Status: terminated.
Semaglutide (Rybelsus) Class II Recall Initiated March 2021
FDA recall record shows a Class II action for Rybelsus (semaglutide) 7 mg tablets, initiated March 15, 2021, over storage temperature deviations. Status: terminated.
Cetrotide (Cetrorelix) Recalled: Class II, Defective Vial Stoppers
EMD Serono initiated a Class II recall of Cetrotide (cetrorelix acetate) on June 29, 2020, citing missing rubber stoppers on drug vials.
Lupron Depot Recall: Class II Action Over Syringe Device Defect
AbbVie initiated a Class II recall of Lupron Depot (leuprolide acetate) kits on March 10, 2014, citing a defective needle stick protection device. Status: terminated.